IMDX vs ROST · rev $271.0K vs P/E 21, rev $22.75B
Insight Molecular Diagnostics Inc. (IMDX) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
IMDX currently screens at market cap $0. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the IMDX and ROST stock pages for the full models.
Not investment advice.